ACSS2 and liver cancer: The critical acetate oxidation enzyme in cancer appears to be the acetyl-CoA synthetase enzyme ACSS2, which was found to be essential for tumorigenesis in a MYC-driven model of liver cancer, and increased expression of ACSS2 was associated with poor prognosis in TNBC (Comerford et al., 2014).